Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure

被引:78
作者
Kang, Woo Dae [1 ]
Oh, Min Jeong [1 ]
Kim, Seok Mo [1 ]
Nam, Jong Hee [2 ]
Park, Chang Soo [2 ]
Choi, Ho Sun [1 ]
机构
[1] Chonnam Natl Univ, Dept Obstet & Gynecol, Sch Med, Gwangu, South Korea
[2] Chonnam Natl Univ, Dept Pathol, Sch Med, Gwangu, South Korea
关键词
high-grade cervical intraepithelial neoplasia; high-risk human papillomavirus testing; loop electrosurgical excision procedure; POSITIVE MARGINS; NATURAL-HISTORY; FOLLOW-UP; CONIZATION; INFECTION; DISEASE; LESIONS;
D O I
10.1016/j.ajog.2010.01.063
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: This study was conducted to determine whether the human papillomavirus (HPV) genotype by the HPV DNA chip test (HDC) is predictive of residual or recurrent high-grade cervical intraepithelial neoplasia (CIN) 2-3 following a loop electrosurgical excision procedure (LEEP). STUDY DESIGN: Between January 2001-February 2007, 672 patients with CIN2-3 were treated by a LEEP and followed up with cytology, the hybrid capture II assay, and the HDC. RESULTS: A total of 37 (5.5%) patients developed a recurrence, and those who developed a recurrence tested positive for the same high-risk (HR) HPV genotype before and after the LEEP. The same HR-HPV genotype by the HDC during the follow-up had a sensitivity and negative predictive value of 100% for detecting residual/recurrent disease. Persistent HPV-16 and HPV-18 were significantly associated with recurrent CIN2-3 (P < .05). CONCLUSION: Persistent infection with the same HR-HPV genotype, especially HPV-16 and HPV-18, should be considered a risk factor for developing residual/recurrent CIN2-3.
引用
收藏
页码:72.e1 / 72.e6
页数:6
相关论文
共 20 条
[1]   Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3 [J].
Alonso, Immaculada ;
Torne, Aureli ;
Puig-Tintore, Luis M. ;
Esteve, Roser ;
Quinto, Llorenc ;
Campo, Elias ;
Pahisa, Jaume ;
Ordi, Jaume .
GYNECOLOGIC ONCOLOGY, 2006, 103 (02) :631-636
[2]   Clinical applications of HPV testing: A summary of meta-analyses [J].
Arbyn, Marc ;
Sasieni, Peter ;
Meijer, Chris J. L. M. ;
Clavel, Christine ;
Koliopoulos, George ;
Dillner, Joakim .
VACCINE, 2006, 24 :78-89
[3]   The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers [J].
Chang, HK ;
Park, J ;
Kim, W ;
Kim, K ;
Lee, M ;
Park, U ;
Choi, B .
GYNECOLOGIC ONCOLOGY, 2005, 97 (02) :342-347
[4]   Detection of HPV genotypes in cervical lesions by the HPV DNA Chip and sequencing [J].
Choi, YD ;
Jung, WW ;
Nam, JH ;
Choi, HS ;
Park, CS .
GYNECOLOGIC ONCOLOGY, 2005, 98 (03) :369-375
[5]   Analytical performance of the Investigational Use Only Cervista™ HPV HR test as determined by a multi-center study [J].
Day, Stephen P. ;
Hudson, Angela ;
Mast, Andrea ;
Sander, Tamara ;
Curtis, Michelle ;
Olson, Sarah ;
Chehak, LuAnne ;
Quigley, Neil ;
Ledford, Joellen ;
Yen-Lieberman, Belinda ;
Kohn, Debra ;
Quigley, Denise I. ;
Olson, Marilyn .
JOURNAL OF CLINICAL VIROLOGY, 2009, 45 :S63-S72
[6]  
FELIX JC, 1994, OBSTET GYNECOL, V84, P996
[7]   Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade III [J].
Gardeil, F ;
BarryWalsh, C ;
Prendiville, W ;
Clinch, J ;
Turner, MJ .
OBSTETRICS AND GYNECOLOGY, 1997, 89 (03) :419-422
[8]   Role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical precancerous lesions [J].
Hernádi, Z ;
Szöke, K ;
Sápy, T ;
Krasznai, ZT ;
Soós, G ;
Veress, G ;
Gergely, L ;
Kónya, J .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 118 (02) :229-234
[9]   Natural history of dysplasia of the uterine cervix [J].
Holowaty, P ;
Miller, AB ;
Rohan, T ;
To, T .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (03) :252-258
[10]   Negative predictive value of human papillomavirus test following conization of the cervix uteri [J].
Jain, S ;
Tseng, CJ ;
Horng, SG ;
Soong, YK ;
Pao, CC .
GYNECOLOGIC ONCOLOGY, 2001, 82 (01) :177-180